KUCA

Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT

Retrieved on: 
Tuesday, October 19, 2021

Hitachi, Tohoku University, and Kyoto University will continue research and development efforts to bring this production technology into commercial use, to help put TAT into clinical practice and ultimately improve cancer patients' quality of life (QoL).

Key Points: 
  • Hitachi, Tohoku University, and Kyoto University will continue research and development efforts to bring this production technology into commercial use, to help put TAT into clinical practice and ultimately improve cancer patients' quality of life (QoL).
  • Hitachi makes effort to pursue research and development that promotes the Security & Safety (healthy and comfortable life for each individual) of society.
  • External radiation uses beams of radiation delivered outside the body to target cancer cells, while internal radiation involves internal delivery of radiation.
  • Research Center for Electron Photon Science (ELPH), Tohoku University Hidetoshi Kikunaga, Associate Professor
    Institute for Integrated Radiation and Nuclear Science, Kyoto University